Adial Pharmaceuticals Inc (ADIL) — Financial Flexibility Index
Adial Pharmaceuticals Inc (ADIL) has a Financial Flexibility Index of -1.07x as of March 2026. Free cash flow of $-1.61 Million (operating CF $-1.61 Million minus capex $0.00) represents -1% of total liabilities ($1.51 Million). Also explore ADIL shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Adial Pharmaceuticals Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Adial Pharmaceuticals Inc across 11 annual periods. Check strategic asset allocation of Adial Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Adial Pharmaceuticals Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Adial Pharmaceuticals Inc. For the full company profile including market capitalisation, see ADIL stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.65x | $-6.49 Million | $-6.49 Million | $1.40 Million | ▲ +34.5% |
| 2024 | -7.09x | $-6.92 Million | $-6.92 Million | $975.86K | — |
| 2023 | 0.00x | $0.00 | $-6.81 Million | $653.51K | ▲ +100.0% |
| 2022 | -4.55x | $-11.19 Million | $-11.19 Million | $2.46 Million | ▼ -58.1% |
| 2021 | -2.88x | $-11.88 Million | $-11.95 Million | $4.13 Million | ▲ +42.7% |
| 2020 | -5.03x | $-7.57 Million | $-7.63 Million | $1.51 Million | ▲ +56.8% |
| 2019 | -11.64x | $-6.27 Million | $-6.34 Million | $539.05K | ▼ -23.4% |
| 2018 | -9.43x | $-2.43 Million | $-2.50 Million | $257.97K | ▼ -1867.6% |
| 2017 | -0.48x | $-494.86K | $-494.86K | $1.03 Million | ▲ +55.4% |
| 2016 | -1.08x | $-274.38K | $-274.38K | $255.02K | ▲ +87.7% |
| 2015 | -8.76x | $-465.22K | $-465.22K | $53.08K | — |